Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01374672 · ClinicalTrials.gov registry record
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 20
- Enrollment target
NCT01374672: Completed study, sponsored by Children's Oncology Group.
NCT01374672 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01374672 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This research study is studying biomarkers in predicting response to chemotherapy in samples from young patients with osteosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
Primary Outcome
Performed on a locus-by-locus basis using Poisson regression (for count data) and/or two-group t-tests, with correction (Satterwaithe's) for unequal within-group variances.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-09 |
What the finished NCT01374672 record still lists
NCT01374672 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01374672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01374672 about?
NCT01374672 is a clinical study titled "Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma". This research study is studying biomarkers in predicting response to chemotherapy in samples from young patients with osteosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related...
What is the current status of trial NCT01374672?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01374672?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01374672?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia